Your browser doesn't support javascript.
loading
Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3ß in the MPP+ treated SH-SY5Y Parkinson's model.
Ahmadzadeh-Darinsoo, Morteza; Ahmadzadeh-Darinsoo, Mojtaba; Abbasi, Shahsanam; Arefian, Ehsan; Bernard, Claude; Tafreshi, Azita Parvaneh.
Afiliación
  • Ahmadzadeh-Darinsoo M; Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
  • Ahmadzadeh-Darinsoo M; Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
  • Abbasi S; Department of Agricultural Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
  • Arefian E; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Bernard C; Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, Victoria, Australia.
  • Tafreshi AP; Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Noncoding RNA Res ; 7(1): 1-6, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35087989
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Noncoding RNA Res Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Noncoding RNA Res Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos